Home › Compare › RUBY vs MO

RUBY vs MO: Dividend Comparison 2026

RUBY yields 3508.77% · MO yields 6.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RUBY wins by $2034141393542.00M in total portfolio value
10 years
RUBY
RUBY
● Live price
3508.77%
Share price
$0.06
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2034141393542.08M
Annual income
$1,926,153,862,282,748,700.00
Full RUBY calculator →
MO
Altria Group Inc.
● Live price
6.36%
Share price
$65.99
Annual div
$4.20
5Y div CAGR
22.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$80.1K
Annual income
$30,159.17
Full MO calculator →

Portfolio growth — RUBY vs MO

📍 RUBY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRUBYMO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RUBY + MO cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
RUBY pays
MO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RUBY
Annual income on $10K today (after 15% tax)
$298,245.61/yr
After 10yr DRIP, annual income (after tax)
$1,637,230,782,940,336,400.00/yr
MO
Annual income on $10K today (after 15% tax)
$540.99/yr
After 10yr DRIP, annual income (after tax)
$25,635.29/yr
At 15% tax rate, RUBY beats the other by $1,637,230,782,940,310,800.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RUBY + MO for your $10,000?

RUBY: 50%MO: 50%
100% MO50/50100% RUBY
Portfolio after 10yr
$1017070696771.08M
Annual income
$963,076,931,141,389,400.00/yr
Blended yield
94.69%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MO right now

RUBY
Analyst Ratings
5
Buy
3
Hold
1
Sell
Consensus: Buy
Altman Z
-81.9
Piotroski
2/9
MO
Analyst Ratings
16
Buy
9
Hold
1
Sell
Consensus: Buy
Price Target
$61.25
-7.2% upside vs current
Range: $47.00 — $68.00
Altman Z
3.2
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RUBY buys
0
MO buys
0
No recent congressional trades found for RUBY or MO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRUBYMO
Forward yield3508.77% ✓6.36%
Annual dividend / share$2.00$4.20 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%22.6% ✓
Portfolio after 10y$2034141393542.08M ✓$80.1K
Annual income after 10y$1,926,153,862,282,748,700.00 ✓$30,159.17
Total dividends collected$2026733119198.63M ✓$74.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyBuy

Year-by-year: RUBY vs MO ($10,000, DRIP)

YearRUBY PortfolioRUBY Income/yrMO PortfolioMO Income/yrGap
1← crossover$361,577$350,877.19$10,570$780.30+$351.0K → RUBY
2$12,243,821$11,856,933.69$11,381$1,032.90+$12.23M → RUBY
3$388,336,948$375,236,059.53$12,535$1,392.73+$388.32M → RUBY
4$11,538,279,357$11,122,758,822.00$14,193$1,920.91+$11538.27M → RUBY
5$321,205,540,543$308,859,581,631.20$16,618$2,723.68+$321205.52M → RUBY
6$8,379,307,864,544$8,035,617,936,162.96$20,263$3,993.80+$8379307.84M → RUBY
7$204,877,671,222,196$195,911,811,807,134.25$25,936$6,098.36+$204877671.20M → RUBY
8$4,695,974,086,156,479$4,476,754,977,948,728.50$35,166$9,775.01+$4695974086.12M → RUBY
9$100,922,926,410,592,910$95,898,234,138,405,470.00$51,026$16,597.78+$100922926410.54M → RUBY
10$2,034,141,393,542,082,800$1,926,153,862,282,748,700.00$80,113$30,159.17+$2034141393542.00M → RUBY

RUBY vs MO: Complete Analysis 2026

RUBY — Stock

Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatment of HPV-positive tumors; and RTX-T1D for treating type 1 diabetes. The company was incorporated in 2013 and is headquartered in Cambridge, Massachusetts.

Full RUBY Calculator →

MO — Consumer Staples

Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company provides cigarettes primarily under the Marlboro brand; cigars and pipe tobacco principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands, as well as provides on! oral nicotine pouches. It sells its tobacco products primarily to wholesalers, including distributors; and large retail organizations, such as chain stores. Altria Group, Inc. was founded in 1822 and is headquartered in Richmond, Virginia.

Full MO Calculator →
📬

Get this RUBY vs MO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RUBY vs SCHDRUBY vs JEPIRUBY vs ORUBY vs KORUBY vs MAINRUBY vs PMRUBY vs BTIRUBY vs PG

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.